111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
13.90%
Revenue growth 1.25-1.5x CX's 10.85%. Bruce Berkowitz would examine if growth advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
-67.09%
Gross profit decline while CX shows 12.71% growth. Joel Greenblatt would examine competitive position.
-71.10%
Margin decline while CX shows 1.68% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.28%
EBITDA decline while CX shows 67.49% growth. Joel Greenblatt would examine position.
-93.64%
EBITDA margin decline while CX shows 145.26% growth. Joel Greenblatt would examine position.
-93.13%
Operating income decline while CX shows 26.06% growth. Joel Greenblatt would examine position.
-93.97%
Operating margin decline while CX shows 13.72% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
143.18%
Tax expense growth while CX reduces burden. John Neff would investigate differences.
13.90%
Net income growth while CX declines. John Neff would investigate advantages.
0.00%
Net margin growth while CX declines. John Neff would investigate advantages.
8.33%
EPS growth while CX declines. John Neff would investigate advantages.
8.33%
Diluted EPS growth while CX declines. John Neff would investigate advantages.
-0.01%
Share count reduction while CX shows 1.30% change. Joel Greenblatt would examine strategy.
-0.05%
Diluted share reduction while CX shows 1.30% change. Joel Greenblatt would examine strategy.